Literature DB >> 4651180

Leucocyte migration and cell-mediated immunity in syphilis.

K W Fulford, J Brostoff.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4651180      PMCID: PMC1048372          DOI: 10.1136/sti.48.6.483

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


× No keyword cloud information.
  14 in total

1.  Lymphocyte abnormality in chronic mucocutaneous candidiasis.

Authors:  H Valdimarsson; L Holt; H R Riches; J R Hobbs
Journal:  Lancet       Date:  1970-06-13       Impact factor: 79.321

2.  Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis.

Authors:  G M Levene; J L Turk; D J Wright; A G Grimble
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

3.  Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes.

Authors:  G Möller
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

4.  [Multiple antigenic stimulation in vitro of lymphocytes of syphilis patients in various stages of the disease].

Authors:  G Chieregato; G Faldarini
Journal:  Minerva Dermatol       Date:  1968-06

5.  Cellular immune response during rejection of a liver transplant in man.

Authors:  A L Eddleston; R Williams; R Y Calne
Journal:  Nature       Date:  1969-05-17       Impact factor: 49.962

6.  Anti-adrenal, cellular hypersensitivity in Addison's disease.

Authors:  J Nerup; V Andersen; G Bendixen
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

7.  Organ-specific inhibition of the in vitro migration of leucocytes in human glomerulonephritis.

Authors:  G Bendixen
Journal:  Acta Med Scand       Date:  1968 Jul-Aug

8.  Immunological relevance of antigen and antigen antibody complex induced lymphocyte transformation.

Authors:  J J Oppenheim
Journal:  Ann Allergy       Date:  1969-07

9.  Changes in leucocyte migration after renal transplantation.

Authors:  M G Smith; A L Eddleston; J A Dominguez; D B Evans; M Bewick; R Williams
Journal:  Br Med J       Date:  1969-11-01

10.  In vitro detection of cellular hypersensitivity in man. Specific migration inhibition of white blood cells from brucella-positive persons.

Authors:  M Soborg
Journal:  Acta Med Scand       Date:  1967-08
View more
  24 in total

1.  Macrophage migration inhibition test in untreated syphilis.

Authors:  J Bowszyc
Journal:  Arch Dermatol Forsch       Date:  1975

2.  Cell response in rabbits infected with T. pallidum as measured by the leucocyte migration inhibition test.

Authors:  V Wicher; K Wicher
Journal:  Br J Vener Dis       Date:  1975-08

3.  Infiltrate of syphilitic lesions before and after treatment.

Authors:  A Tosca; J Lehou; M Hatjivasiliou; A Varelzidis; J D Stratigos
Journal:  Genitourin Med       Date:  1988-10

Review 4.  Why is the infectious stage of syphilis prolonged?

Authors:  D J Wright; A S Grimble
Journal:  Br J Vener Dis       Date:  1974-02

5.  Activation of macrophages by products of lymphocytes from normal and syphilitic rabbits.

Authors:  S A Lukehart
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

6.  Sequential changes in susceptibility to Treponema pallidum of rabbits previously infected with Treponema paraluis-cuniculi.

Authors:  S Graves
Journal:  Br J Vener Dis       Date:  1981-02

7.  In vitro lymphocyte response to Treponema refringens im human syphilis.

Authors:  D M Musher; R F Schell; J M Knox
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

Review 8.  Cell-mediated immunity during syphilis.

Authors:  C S Pavis; J D Folds; J B Baseman
Journal:  Br J Vener Dis       Date:  1978-06

9.  Reactivity of lymphocytes from patients with syphilis towards T. pallidum antigen in the leucocyte migration and lymphocyte transformation tests.

Authors:  E From; K Thestrup-Pedersen; H Thulin
Journal:  Br J Vener Dis       Date:  1976-08

10.  [Lymphokine activity in mercury stimulated leucocyte cultures (author's transl)].

Authors:  G Lischka
Journal:  Arch Dermatol Res       Date:  1976-03-10       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.